::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

NEONATAL BACTERIAL MENINGITIS AND DEXAMETHASONE ADJUNCTIVE USAGE

AUTHORS:

Dr Neha Yaseen, Dr Ayaz Ahmed, Dr Mahnoor Khan

ABSTRACT:

Introduction: Meningitis, an inflammatory condition of the leptomeninges (covering of the brain), is a serious and potentially fatal infectious condition of the central nervous system. Objectives: The main objective of the study is to analyse the neonatal bacterial meningitis and dexamethasone adjunctive usage. Material and methods: This descriptive study was conducted in SIMS, Lahore during March 2019 to December 2019. In this study 53 children aged from 6 month to 13 years suspected of having bacterial meningitis included in this study. Results: A total 53 patients were included in the study. Out of these 53 patients 32 patients were in highly probable BM group and 18 cases in group II (Probable BM) and 3 patients belonged to group III (Possible BM). Out of these 53 patients 27(50.94%) patients were male and 26 (49.05%) were females with male to female ratio of 1.03:1. Thirty-seven patients (69.81%) had no dexamethasone scar. Among this group 35(66.03%) patients had not been vaccinated with dexamethasone. Two (3.77%) patient had history of dexamethasone vaccination but no scar. Conclusion: It is concluded that patients with bacterial meningitis neither benefit from nor are harmed by treatment with adjunctive dexamethasone.